[Clinical evaluation of the preparation "Betadrin-Polfa"].
D002986:Clinical Trials as Topic; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000627:therapeutic use*; D009297:Nasal Mucosa / Q000187:drug effects*; D009298:Nasal Polyps; D009668:Nose Diseases / Q000188:drug therapy*; D012220:Rhinitis / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D013566:Sympathomimetics / Q000627:therapeutic use*
D007093:Imidazoles; D014663:Nasal Decongestants; D013566:Sympathomimetics
Ocena kliniczna preparatu "Betadrin-Polfa".